Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Sajatovic, M.
* Articles by Bingham, C. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Sajatovic, M.
* Articles by Bingham, C. R.
Related Collections
* Schizophrenia Spectrum Disorders
* Symptoms/Dimensions
* Atypical Neuroleptics
* Conventional Neuroleptics
Psychiatr Serv 53:1319-1321, October 2002
© 2002 American Psychiatric Association


Brief Report

Insight Into Illness and Attitudes Toward Medications Among Inpatients With Schizophrenia

Martha Sajatovic, M.D., Debra S. Rosch, Ph.D., Harry J. Sivec, Ph.D., Dilara Sultana, M.D., Douglas A. Smith, M.D., Samer Alamir, M.D., Peter Buckley, M.D. and C. Raymond Bingham, Ph.D.

This study assessed symptoms, severity of illness functional level, insight into illness, and attitudes toward medication in a sample of psychiatric patients who were newly admitted to a state hospital. The patients were evaluated before and after treatment with atypical, conventional, or mixed (atypical plus conventional) antipsychotic medication regimens with the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impression, the Global Assessment of Functioning, the Scale to Assess Unawareness of Mental Disorder, and the Drug Attitude Inventory. Overall, the patients showed significant improvement in symptoms, severity of illness, functional level, and insight into their illness during the course of hospitalization. Their attitudes toward medications changed minimally during treatment. Only the patients who were treated with conventional antipsychotics showed significant improvement in their attitudes toward medication. However, the change was not large enough to differentiate the conventional antipsychotic treatment group from the other treatment groups.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
S. Burton
Symptom domains of schizophrenia: the role of atypical antipsychotic agents.
J Psychopharmacol, November 1, 2006; 20(6 Suppl): 6 - 19.
[Abstract] [PDF]


Home page
Psychiatr. Serv.Home page
C. Lauber, C. Nordt, and W. Rossler
Patients' Attitudes Toward Antidepressants
Psychiatr Serv, May 1, 2003; 54(5): 746 - 747.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org